BAYERCROP:NSE-Bayer CropScience Limited (INR)

COMMON STOCK | Agricultural Inputs | NSE

Last Closing Price

INR 5,851.30

Change

+77.35 (+1.34)%

Market Cap

INR 259.95B

Volume

0.01M

Avg Analyst Target

INR 6,022.00 (+2.92%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India. It also provides pharmaceutical products, such as prescription products primarily for cardiology, oncology, gynecology, hematology, and ophthalmology; and diagnostic imaging equipment and other contrast agents. In addition, the company offers consumer health products that are used as a daily health solutions to treat minor illness; and animal health solutions for the prevention and treatment of diseases in companion and farm animals, as well as sells and distributes hybrid seeds. It also exports its products. The company was incorporated in 1958 and is based in Thane, India.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-28 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UPL:NSE UPL Limited

+1.90 (+0.23%)

INR620.98B 22.33 10.38
PIIND:NSE PI Industries Limited

-45.15 (-1.50%)

INR455.43B 60.17 39.02
COROMANDEL:NSE Coromandel International Limit..

-15.55 (-1.75%)

INR260.26B 19.62 12.88
CHAMBLFERT:NSE Chambal Fertilisers and Chemic..

-3.10 (-1.02%)

INR126.76B 7.66 5.04
FACT:NSE The Fertilisers And Chemicals ..

-3.10 (-2.29%)

INR87.68B 24.91 15.82
RALLIS:NSE Rallis India Limited

+2.30 (+0.73%)

INR61.17B 27.90 16.40
BHARATRAS:NSE Bharat Rasayan Limited

-265.20 (-1.98%)

INR56.89B 34.69 23.01
DHANUKA:NSE Dhanuka Agritech Limited

+0.60 (+0.06%)

INR46.63B 22.42 14.86
GSFC:NSE Gujarat State Fertilizers & Ch..

+0.10 (+0.09%)

INR46.34B 10.29 4.77
RCF:NSE Rashtriya Chemicals and Fertil..

-0.55 (-0.68%)

INR44.25B 11.79 5.23

ETFs Containing BAYERCROP

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Agricultural Inputs)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.59% 14% F 19% F
Dividend Return 0.46% 56% F 22% F
Total Return 8.05% 11% F 19% F
Trailing 12 Months  
Capital Gain 1.27% 7% F 7% F
Dividend Return 0.43% 33% F 14% F
Total Return 1.70% 7% F 7% F
Trailing 5 Years  
Capital Gain 46.07% 30% F 54% F
Dividend Return 3.22% 41% F 42% F
Total Return 49.29% 30% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 10.25% 39% F 55% F
Dividend Return 0.55% 44% F 63% D
Total Return 10.80% 39% F 54% F
Risk Return Profile  
Volatility (Standard Deviation) 29.46% 93% A 83% B
Risk Adjusted Return 36.64% 68% D+ 71% C-
Market Capitalization 259.95B 89% B+ 90% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Agricultural Inputs)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 52.62 12% F 23% F
Price/Book Ratio 10.29 4% F 8% F
Price / Cash Flow Ratio 37.85 11% F 14% F
EV/EBITDA 28.45 12% F 24% F
Management Effectiveness  
Return on Equity 19.25% 80% B- 83% B
Return on Invested Capital 17.05% 86% B 86% B
Return on Assets 11.43% 89% B+ 91% A-
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.53 82% B- 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector